Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Host-directed therapies against early-lineage SARS-CoV-2 ... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
0
Authors
Ann‐Kathrin Reuschl
27 more
Ann‐Kathrin Reuschl
•
Jacqueline Fabius
25 more
•
Nevan Krogan
Published
February 4, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Microbiology
Medicine
Pathology
Genetics
Show all topics
DOI
10.1101/2021.01.24.427991
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Microbiology
Medicine
Pathology
Genetics
Show all topics
DOI
10.1101/2021.01.24.427991
License
CC-BY-NC-ND
Other Formats
PDF
